Dorsey Wright & Associates’s Lunai Bioworks LNAI Stock Holding History

Dorsey Wright & Associates’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-98	Closed	-$53K	–	325
2021 Q3	$53K	Buy	+98	New	+$47.9K	0.01%	193

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dorsey Wright & Associates's LNAI Position: Q4 2021 in Review

Dorsey Wright & Associates sold out of Lunai Bioworks (LNAI) in Q4 2021, closing a stake of 98 shares — an estimated $53K sold.

Dorsey Wright & Associates first reported a position in LNAI in Q3 2021 and held it in 1 quarter. The position peaked at $53K in Q3 2021. 44 funds tracked by Wall St. Rank hold LNAI as of Q4 2021.

Dorsey Wright & Associates reported no remaining Lunai Bioworks position as of Q4 2021 after selling out during the quarter.
Dorsey Wright & Associates sold 98 Lunai Bioworks shares in Q4 2021, an estimated $53K.
Dorsey Wright & Associates first reported a position in Lunai Bioworks in Q3 2021 and held it in 1 quarter.
Dorsey Wright & Associates's Lunai Bioworks position peaked at $53K in Q3 2021.
44 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2021.

Based on Dorsey Wright & Associates's 13F filing for Q4 2021, filed 27 Jan 2022.